Adherence to preventive statin therapy according to socioeconomic position

Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › fagfællebedømt

Standard

Adherence to preventive statin therapy according to socioeconomic position. / Wallach-Kildemoes, Helle ; Andersen, Morten; Diderichsen, Finn; Lange, Theis.

I: European Journal of Clinical Pharmacology, Bind 69, Nr. 8, 08.2013, s. 1553-1563.

Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › fagfællebedømt

Harvard

Wallach-Kildemoes, H, Andersen, M, Diderichsen, F & Lange, T 2013, 'Adherence to preventive statin therapy according to socioeconomic position', European Journal of Clinical Pharmacology, bind 69, nr. 8, s. 1553-1563. https://doi.org/10.1007/s00228-013-1488-6

APA

Wallach-Kildemoes, H., Andersen, M., Diderichsen, F., & Lange, T. (2013). Adherence to preventive statin therapy according to socioeconomic position. European Journal of Clinical Pharmacology, 69(8), 1553-1563. https://doi.org/10.1007/s00228-013-1488-6

Vancouver

Wallach-Kildemoes H, Andersen M, Diderichsen F, Lange T. Adherence to preventive statin therapy according to socioeconomic position. European Journal of Clinical Pharmacology. 2013 aug.;69(8):1553-1563. https://doi.org/10.1007/s00228-013-1488-6

Author

Wallach-Kildemoes, Helle ; Andersen, Morten ; Diderichsen, Finn ; Lange, Theis. / Adherence to preventive statin therapy according to socioeconomic position. I: European Journal of Clinical Pharmacology. 2013 ; Bind 69, Nr. 8. s. 1553-1563.

Bibtex

@article{9193753e6b12452483178aab4ec84dd6,
title = "Adherence to preventive statin therapy according to socioeconomic position",
abstract = "AIM: To explore whether long-term adherence to preventive statin therapy depends on socioeconomic position (SEP). METHODS: A cohort of individuals without established cardiovascular disease (CVD) or diabetes initiating preventive statin therapy during 2002-2005 was followed in the individual-level Danish registries for 4 years or until censoring events (death, emigration, CVD or diabetes). Only individuals aged 40-84 years for whom information was available on the SEP indicators, education and income were included (N = 76,038). Two different aspects of poor adherence were applied as outcome measures: (1) Proportion of days covered (PDC) with medication below 80 %, assuming a daily dose of one tablet (continuity); (2) Discontinuation defined as a gap between two consecutive prescriptions exceeding 365 days (persistence). Stratum-specific logistic regression analyses were applied to estimate the odds ratio (OR) for PDC ",
author = "Helle Wallach-Kildemoes and Morten Andersen and Finn Diderichsen and Theis Lange",
year = "2013",
month = aug,
doi = "10.1007/s00228-013-1488-6",
language = "English",
volume = "69",
pages = "1553--1563",
journal = "European Journal of Clinical Pharmacology",
issn = "0031-6970",
publisher = "Springer",
number = "8",

}

RIS

TY - JOUR

T1 - Adherence to preventive statin therapy according to socioeconomic position

AU - Wallach-Kildemoes, Helle

AU - Andersen, Morten

AU - Diderichsen, Finn

AU - Lange, Theis

PY - 2013/8

Y1 - 2013/8

N2 - AIM: To explore whether long-term adherence to preventive statin therapy depends on socioeconomic position (SEP). METHODS: A cohort of individuals without established cardiovascular disease (CVD) or diabetes initiating preventive statin therapy during 2002-2005 was followed in the individual-level Danish registries for 4 years or until censoring events (death, emigration, CVD or diabetes). Only individuals aged 40-84 years for whom information was available on the SEP indicators, education and income were included (N = 76,038). Two different aspects of poor adherence were applied as outcome measures: (1) Proportion of days covered (PDC) with medication below 80 %, assuming a daily dose of one tablet (continuity); (2) Discontinuation defined as a gap between two consecutive prescriptions exceeding 365 days (persistence). Stratum-specific logistic regression analyses were applied to estimate the odds ratio (OR) for PDC

AB - AIM: To explore whether long-term adherence to preventive statin therapy depends on socioeconomic position (SEP). METHODS: A cohort of individuals without established cardiovascular disease (CVD) or diabetes initiating preventive statin therapy during 2002-2005 was followed in the individual-level Danish registries for 4 years or until censoring events (death, emigration, CVD or diabetes). Only individuals aged 40-84 years for whom information was available on the SEP indicators, education and income were included (N = 76,038). Two different aspects of poor adherence were applied as outcome measures: (1) Proportion of days covered (PDC) with medication below 80 %, assuming a daily dose of one tablet (continuity); (2) Discontinuation defined as a gap between two consecutive prescriptions exceeding 365 days (persistence). Stratum-specific logistic regression analyses were applied to estimate the odds ratio (OR) for PDC

U2 - 10.1007/s00228-013-1488-6

DO - 10.1007/s00228-013-1488-6

M3 - Journal article

C2 - 23588558

VL - 69

SP - 1553

EP - 1563

JO - European Journal of Clinical Pharmacology

JF - European Journal of Clinical Pharmacology

SN - 0031-6970

IS - 8

ER -

ID: 45664308